Singer, CF; Jahn, SW; Hlauschek, D; Heber, UM; Mang-Manger, C; Egle, D; Balic, M; Pichler, A; Pfeiler, G; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Petru, E; Greil, R; Bago-Horvath, Z; Deutschmann, C; Steger, GG; Seifert, M; Fitzal, F; Bartsch, R; Santhanagopal, A; Machacek-Link, J; Sellami, D; Schwarz, M; Fesl, C; Sölkner, L; Esker, S; Filipits, M; Gnant, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group.
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Cancer Commun (Lond). 2025;
Doi: 10.1002/cac2.12657
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG